Med-Tech Innovation September 26, 2024
Olivia Friett

University of Iowa Health Care and Naitive Technologies are excited to announce a joint project to evaluate the diagnostic accuracy of OsteoSight, an FDA-designated medical device designed to identify people at risk of low bone mineral density (BMD) using X-rays taken for other reasons.

OsteoSight aims to enhance the early detection of osteoporosis, a condition affecting millions globally, and enable more timely interventions.

The primary focus of this project is to evaluate the accuracy of OsteoSight in identifying individuals at risk of low BMD, as compared to the current gold standard dual-energy X-ray absorptiometry scan (DEXA). The study will also investigate any potential biases in the machine learning model and evaluate the reasons behind any instances of failed image...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Medical Devices, Provider
How 3 hospitals are reimagining behavioral crisis care
How Health Systems Can Collaborate on AI Tools
Critical access hospitals face uphill battle: 6 things to know
AdventHealth's plans for new Florida hospital move forward
OSU Wexner CEO's blueprint for improving care in 2025

Share This Article